REGULATION OF IL‐6‐SIGNALING AND INFLAMMATORY RESPONSE
‐ ROLE OF INSULIN, FOXO1 AND PKCδ
Emelie Wallerstedt
The Lundberg Laboratory for Diabetes Research The Sahlgrenska Academy at University of Gothenburg
The aim of this thesis was to investigate if and how insulin antagonizes interleukin-6 (IL-6)-signaling and action using both 3T3-L1 mouse adipocytes (Paper I) and HepG2 human hepatocytes (Paper III). We also investigated the importance of PKCδ in 3T3-L1 adipocytes and mouse embryonic fibroblasts (MEFs) lacking protein kinase C-δ (PKCδ-/-) (Paper II).
Obesity is associated with a low grade chronic inflammation in the adipose tissue as enlarged adipocytes and macrophage infiltration increase the secretion of inflammatory molecules, such as IL-6, which further enhance the inflammatory response in the adipose tissue and liver.
Insulin was found to exert an anti-inflammatory effect on IL-6- signaling in 3T3-L1 adipocytes by reducing the tyrosine phosphorylation of the transcription factor STAT3, increasing the serine phosphorylation of STAT3 and, furthermore, reducing the nuclear translocation and the transcriptional activity of STAT3. In addition, we found that insulin both induced activation of the phosphatase SHP2, which dephosphorylates STAT3, and synergistically increased gene expression of the suppressor of cytokine signaling (Socs3) and thus, impairing IL-6-signaling. These effects also reduced IL-6-induced gene expression of inflammatory genes such as serum amyloid A 3 (Saa3) and haptoglobin (Hp). The effect of insulin was mediated through a MEK-mitogen-activated protein kinase (MAPK) pathway since PD98059 (MEK-inhibitor) reduced the inhibitory effects of insulin (Paper I).
The anti-inflammatory effect of insulin was also observed in HepG2 hepatocytes. Insulin reduced the IL-6-induced transcription of SAA1, SAA2, HP, plasmin activator inhibitor 1 (PAI-1) and orosomucoid 1 (ORM1).
However, the signaling mechanism for how insulin exerts its anti- inflammatory effect in HepG2 hepatocytes differed from that of 3T3-L1 adipocytes as insulin also stimulates nuclear exit of forkhead box O1 (FOXO1);
a co-activator of STAT3 (Paper III).
Furthermore, the tyrosine and serine phosphorylation of STAT3
was found to be dependent on the serine and threonine kinase PKCδ, as the
specific PKCδ inhibitor rottlerin reduced these phosphorylations in 3T3-L1
adipocytes. Consequently, the nuclear translocation of STAT3, the IL-6-
induced gene transcription of Socs3, Il-6, Saa3 and Hp as well as the protein
secretion of SAA3, were all reduced. Furthermore, PKCδ was found to
translocate to the nucleus following IL-6 and this was reduced by rottlerin. In agreement with the effect of rottlerin, PKCδ-/- MEFs also displayed a markedly reduced ability of IL-6 to activate the gene transcription of Saa3, Hp, Socs3 and Il-6 genes when compared to wild type (wt) MEFs. These results associated with a reduced nuclear translocation and phosphorylations of STAT3 (Paper II).
In conclusion, we have found that insulin exerts anti-inflammatory effects by antagonizing IL-6-signaling and action in both 3T3-L1 adipocytes and HepG2 heptocytes. PKCδ was also found to play an important role in STAT3 activation and for IL-6-induced inflammation in 3T3-L1 adipocytes while FOXO1 seems of importance as a co-activator in HepG2 cells. Future studies should be focused on the interplay between PKCδ and FOXO1, which can increase our knowledge of cytokine-induced inflammation and development of new anti-inflammatory treatments.
Keywords: Type 2-Diabetes, inflammation, obesity, IL-6, STAT3, PKCδ, FOXO1
ISBN: 978-91-628-8040-8 Göteborg 2010
LIST OF PUBLICATIONS
The thesis is based on the following papers that will be referred to their roman numerals:
I. Andersson CX, Sopasakis VR, Wallerstedt E, Smith U. Insulin antagonizes interleukin-6 signaling and is anti-inflammatory in 3T3-L1 adipocytes. J Biol Chem. 2007 Mar 30;282(13):9430-5.
II. Wallerstedt E, Smith U, Andersson CX. Protein kinase C- δ is involved in the inflammatory effect of IL-6 in mouse adipose cells. Diabetologia.
2010 Feb 12. [Epub ahead of print].
III. Wallerstedt E, Sandqvist M, Smith U, Andersson CX. Anti- inflammatory effect of insulin in the human hepatoma cell line HepG2.
Submitted 2010.
LIST OF ABBREVIATIONS
ABCA1 ATP-binding cassette transporter 1 AMPK 5´-AMP-activated protein kinase
aP2 Adipocyte protein 2
BAT Brown adipose tissue
BCA Bicinchonic acid
BMI Body mass index
BP Blood pressure
C/EBP-β CCAAT/enhancer binding protein-β
C3 Complement factor 3
CNS Central nervous system
CRP C-reactive protein
CVD Cardiovascular disease
DAG Diacylglycerol
DDT Dichlorodiphenyltrichloroethane
EGR-1 Early growth response factor-1 eNOS Endothelial nitric oxide synthases
ES Embryonic stem cells
FFA Free fatty acids
FOXO1 Forkhead box O1
FPG Fasting plasma glucose
G6Pase Glucose-6-phosphatase
GLUT2, 4 Glucose transporter 2, 4
gp130 Glycoprotein 130
HDL High density lipoprotein
HP Haptoglobin
HRP Horseradish peroxidase
ICV intracerebroventricular
IGF-1 Insulin-like growth factor-1
IKK IκB kinase
IL-6 Interleukin-6
IL-6R IL-6 receptor
IP Intraperitoneal
IR Insulin receptor
IRS-1, 2 Insulin receptor substrate-1, 2
IκB Inhibitor of κB
JAK Janus kinase
JNK c-JUN NH
2-terminal kinase
LPL Lipoprotein lipase
MAPK Mitogen-activated protein kinase
MCP-1 Monocyte chemotactic protein-1
MEF Mouse embryonic fibroblast
NAFLD Non-alcoholic fatty liver disease NASH Non-alcoholic steatohepatitis
NF-κB Nuclear factor κB
NO Nitric oxide
ORM1 Orosomucoid 1
PAI-1 Plasmin activator inhibitor 1
PDK1, 2 Pyruvate dehydrogenase kinase isozyme 1, 2 PEPCK Phosphoenolpyruvate carboxykinase
PGC-1α Peroxisome proliferator-activated receptor-γ coactivator-1
PHA Phytohaemagglutinin
PI3-kinase Phosphoinositide 3-kinases
PIAS Protein inhibitor of STAT3
PIP
2Phosphatidylinositol 4, 5-bisphosphate PIP
3Phosphatidylinositol 3, 4, 5-trisphosphate
PKB Protein Kinase B
PKCδ Protein kinase C-δ
PKCδKN Kinase-negative PKCδ
PPARα, γ Peroxisome proliferator-activated receptors α, γ PTB1B Protein tyrosine phosphatase 1B
ROS Reactive oxygen species
SAA Serum amyloid
SDS-PAGE Sodium dodecyl sulphate polyacrylmide gel electrophoresis
SH-2 Scr homology-2
SHP2 SH-2-domain containing tyrosine phosphatase sICAM-1 Soluble intercellular adhesion molecule-1 SOCS3 Suppressor of cytokine signaling
SREBP-1c Sterol regulatory element binding protein-1c STAT Signal transducer and activator of transcription SUMO Small ubiquitin-like modifier
T2D Type 2 diabetes
TG Triglyceride
TLR2, 4 Toll like receptor 2, 4
TNFα Tumor necrosis alpha
TTP Tristetraprolin
UCP-1 Uncoupling protein-1
VLDL-TG Very low-density lipoprotein- triglyceride
vSMC Vascular smooth muscle cells
WAT White adipose tissue
WT Wild type
TABLE OF CONTENTS
ABSTRACT...5
LIST OF PUBLICATIONS ...7
LIST OF ABBREVIATIONS...8
TABLE OF CONTENTS ... 10
INTRODUCTION... 11
T
YPE2
DIABETES(T2D)
AND INSULIN RESISTANCE...11
F
UNCTION OF INSULIN IN ADIPOCYTES...12
A
DIPOSE TISSUE AS AN ENDOCRINE ORGAN...15
A
DIPOSE TISSUE INFLAMMATION...17
L
IVER STEATOSIS...19
IL‐6‐
SIGNALING...20
C
ROSS‐
TALK BETWEENIL‐6‐
SIGNALING AND INSULIN SIGNALING...22
IL‐6
LEVELS IN INSULIN RESISTANT SUBJECTS...22
PKCδ...23
AIM ... 25
EXPERIMENTAL PROCEDURES... 26
C
ELL CULTURE...26
3T3L1... 26
Human hepatoma cell line, HepG2 ... 26
SHP2/ MEFs and wt MEFs ... 26
PKCδ/ MEFs and wt MEFs... 26
P
ROTEIN EXTRACTION...27
Whole cell extract ... 27
Subcellular fractionation... 27